Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance.
about
In vivo imaging of the Muc5b gel-forming mucinNeutrophil elastase stimulates MUC5AC expression in human biliary epithelial cells: a possible pathway of PKC/Nox/ROS.Oral benzo[a]pyrene-induced cancer: two distinct types in different target organs depend on the mouse Cyp1 genotype.Biliary epithelial apoptosis, autophagy, and senescence in primary biliary cirrhosisMucins as diagnostic and prognostic biomarkers in a fish-parasite model: transcriptional and functional analysisGNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile ductTrefoil Factor 3 (TFF3) Is Regulated by Food Intake, Improves Glucose Tolerance and Induces Mucinous Metaplasia.Dietary Leucine Supplementation Improves the Mucin Production in the Jejunal Mucosa of the Weaned Pigs Challenged by Porcine Rotavirus.Excess Secretion of Gel-Forming Mucins and Associated Innate Defense Proteins with Defective Mucin Un-Packaging Underpin Gallbladder Mucocele Formation in Dogs.Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation.Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis.CFTR, mucins, and mucus obstruction in cystic fibrosis.Nuclear Factor Erythroid 2-Related Factor 2 Deficiency Results in Amplification of the Liver Fat-Lowering Effect of Estrogen.The GCTM-5 epitope associated with the mucin-like glycoprotein FCGBP marks progenitor cells in tissues of endodermal originRole of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinomaTumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach.Tutorial review for understanding of cholangiopathyThe intestinal glycome and its modulation by diet and nutrition.Suppression of mucin 2 enhances the proliferation and invasion of LS174T human colorectal cancer cells.Cystic and Papillary Neoplasm at the Hepatic Hilum Possibly Originating in the Peribiliary Glands.Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.Participation of peribiliary glands in biliary tract pathophysiologies.LPS increases MUC5AC by TACE/TGF-α/EGFR pathway in human intrahepatic biliary epithelial cell.γδ T cells play a protective role during infection with Nippostrongylus brasiliensis by promoting goblet cell function in the small intestine.Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival.Clinicopathological features of combined hepatocellular-cholangiocarcinoma with sarcomatous change: Case report and literature review.Hilar cholangiocarcinoma is pathologically similar to pancreatic duct adenocarcinoma: suggestions of similar background and development.Development of an animal model of fibrous cholangitis in pigs.Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct.Intraductal papillary neoplasm arising from peribiliary glands connecting with the inferior branch of the bile duct of the anterior segment of the liver.
P2860
Q30842046-54AAD18E-1927-47AF-9A93-26B7F2216176Q33645999-7D4922CB-D94E-4F6E-AB50-B28212509375Q34050632-BCBA20D0-77AB-4E97-8878-BCFBED425797Q34341006-80AEAB8F-455B-4178-AFB4-DC8EE5538B58Q34775719-82DC3F27-1FA8-4729-80A9-370CD7F839F2Q35061297-79B34BC2-49DE-43C8-BAE6-798C9F85955CQ35666227-CF93A39B-3F96-4546-8CF3-AE64CA1C02D0Q35763718-38E93CDF-814D-4A71-9832-30E887475215Q35790500-59F6D76E-4736-4937-95BC-5CA62A50CCA4Q35864132-898FCFC1-E3D4-4495-8B4B-EF3750FDC10FQ36053164-BF1E05B9-2992-4169-B72A-4F3A0364454EQ36186528-BCFB7107-FF6B-47F2-AC12-2A4CBB02C924Q37062567-CF42B07E-EF7E-488E-BE55-52B3860F9154Q37183566-BC40D48E-542D-4626-B8BC-87E082534390Q37351498-2A30A4DE-6552-4A0F-81AE-6063208E5FE0Q37579703-E9AD3138-C0D2-4656-B703-B99D517F86CFQ37945249-BAD822D6-B0A3-4BCB-AED5-A4CA464690E4Q38503059-CFBF0599-2896-4D05-8D73-655B242ECEDCQ39538027-1B6BCB06-0BE2-45A9-A7AF-515FAA54CCEBQ41083099-767CCDD0-276C-4F2F-950F-C241AD23FB4BQ41129198-77B4EFA7-3F98-409A-878D-EB35C8DCC054Q41825967-C3CA288F-B235-4A1F-B1D9-FD22C1C5C425Q42042162-8EB18D48-59B8-434A-832A-F8CB42232C32Q43459851-E0312343-117E-427B-923F-2CD594C996E6Q45728401-3E3691AD-E6F8-4F61-B005-797F536857DDQ49319789-2A9479D0-8FE5-401B-839B-D16DB90148FAQ50694709-3DE585C0-428F-4CF2-9D1F-9BC743304F18Q50696819-C755E550-3D7D-4944-9DFD-0557E47987A6Q51295478-7457F156-50E4-4B04-AB6A-AB1F30DDAB9EQ51382063-C9EE2151-9205-444B-8032-438EDE9A7759
P2860
Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Expression profiles of MUC muc ...... and pathological significance.
@en
type
label
Expression profiles of MUC muc ...... and pathological significance.
@en
prefLabel
Expression profiles of MUC muc ...... and pathological significance.
@en
P2093
P1476
Expression profiles of MUC muc ...... and pathological significance.
@en
P2093
Hiroko Ikeda
Motoko Sasaki
Yasuni Nakanuma
P304
P356
10.1016/J.PROGHI.2007.02.001
P577
2007-04-19T00:00:00Z